Journal
BIOMEDICINES
Volume 9, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines9050524
Keywords
Alzheimer's disease; neuroinflammation; immunosenescence; inflammasome; mitochondria; microglia; astrocytes; DAMPs; SASP
Categories
Funding
- European Regional Development Fund [ENOCH 750, CZ.02.1.01/0.0/0.0/16_019/0000868]
Ask authors/readers for more resources
Alzheimer's disease is a neurodegenerative disease associated with aging, with no effective treatments currently available. Inflammaging may contribute to the progression of neurodegeneration in AD.
Alzheimer's disease (AD) is a neurodegenerative disease associated with human aging. Ten percent of individuals over 65 years have AD and its prevalence continues to rise with increasing age. There are currently no effective disease modifying treatments for AD, resulting in increasingly large socioeconomic and personal costs. Increasing age is associated with an increase in low-grade chronic inflammation (inflammaging) that may contribute to the neurodegenerative process in AD. Although the exact mechanisms remain unclear, aberrant elevation of reactive oxygen and nitrogen species (RONS) levels from several endogenous and exogenous processes in the brain may not only affect cell signaling, but also trigger cellular senescence, inflammation, and pyroptosis. Moreover, a compromised immune privilege of the brain that allows the infiltration of peripheral immune cells and infectious agents may play a role. Additionally, meta-inflammation as well as gut microbiota dysbiosis may drive the neuroinflammatory process. Considering that inflammatory/immune pathways are dysregulated in parallel with cognitive dysfunction in AD, elucidating the relationship between the central nervous system and the immune system may facilitate the development of a safe and effective therapy for AD. We discuss some current ideas on processes in inflammaging that appear to drive the neurodegenerative process in AD and summarize details on a few immunomodulatory strategies being developed to selectively target the detrimental aspects of neuroinflammation without affecting defense mechanisms against pathogens and tissue damage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available